Insomnia
Conditions
Interventions
high dose group:Take 4 hydrolyzed casein peptide tablets
placebo group:Take 4 placebo tablets
low dose group:Take 2 hydrolyzed casein peptide tablets
Sponsors
Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Age 18-65 years old. 2) Gender is not limited. 3) Body mass index 18.5-23.9 kg/m2. 4) Normal vital signs (blood pressure below 140/90 mmHg (i.e., systolic blood pressure below 140 mmHg, diastolic blood pressure below 90 mmHg, and heart rate between 60-100 bpm). 5) Pittsburgh Sleep Quality Index score >7. 6) Meet the symptoms of primary insomnia. 7) Have signed a written informed consent.
Exclusion criteria
Exclusion criteria: 1)Patients who have been diagnosed with major anxiety and depression. 2)Persons with alcohol or drug dependence. 3) Smoking more than 10 cigarettes per day. 4) Allergic to milk protein or hydrolyzed casein peptide components. 5) Patients with secondary insomnia. 6) Have used medication for insomnia in the month prior to inclusion. 7) Ongoing non-pharmacological treatment for insomnia (e.g., cognitive behavioral therapy, relaxation therapy, etc.). 8) Pregnant or breastfeeding. 9) Those with cancer or other major medical conditions. 10) Those who are unwilling or unable to complete the entire trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective sleep quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective sleep quality;Subjective daytime function; | — |
Countries
China
Contacts
Public ContactSun Jin
Qingdao University
Outcome results
None listed